Incorporating patient preferences into randomized trials

被引:44
作者
Lambert, MF [1 ]
Wood, J [1 ]
机构
[1] Univ York, Dept Hlth Sci & Clin Evaluat, York YO1 5DD, N Yorkshire, England
关键词
clinical trials/methods; clinical trials/standards; medical ethics; informed consent;
D O I
10.1016/S0895-4356(99)00146-8
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
When designing trials, an important ethical and practical concern is ensuring that proper consideration is given to patient preferences. A number of design variants on the traditional randomized trial can take account of such preferences in different ways. The partially randomized patient preference (PRPP) design is often advocated for taking these preferences into account. In studies of this type, all eligible patients are followed up, but the primary comparison is still between effects observed in patients randomly allocated to treatment arms. This design and other variants on conventional trials each have different scientific, ethical, and practical implications. We consider these diverse aspects of several modifications to the conventional method for obtaining consent and then, in more detail, the relative merits of the PRPP design. We conclude that none of these adjustments is ideal. Those designing trials should therefore always think carefully about the consent process, for its implications on participation and on how the results will be interpreted. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:163 / 166
页数:4
相关论文
共 8 条
[2]   PATIENT PREFERENCES AND RANDOMIZED CLINICAL-TRIALS [J].
BREWIN, CR ;
BRADLEY, C .
BRITISH MEDICAL JOURNAL, 1989, 299 (6694) :313-315
[3]   The impact of using a partially randomised patient preference design when evaluating alternative managements for heavy menstrual bleeding [J].
Cooper, KG ;
Grant, AM ;
Garratt, AM .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 (12) :1367-1373
[4]   NEW KINDS OF SYSTEMATIC DESIGNS FOR SPACING EXPERIMENTS [J].
NELDER, JA .
BIOMETRICS, 1962, 18 (03) :283-+
[5]  
SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V274, P1456
[6]   EXPLANATORY AND PRAGMATIC ATTITUDES IN THERAPEUTICAL TRIALS [J].
SCHWARTZ, D ;
LELLOUCH, J .
JOURNAL OF CHRONIC DISEASES, 1967, 20 (08) :637-&
[7]  
Torgerson D J, 1996, J Health Serv Res Policy, V1, P194
[8]  
ZELEN M, 1982, CANCER TREAT REP, V66, P1095